Inflammation, Depression and Dementia: Are they Connected?
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Chronic inflammation is now considered to be central to the pathogenesis not only of such medical disorders as cardiovascular disease, multiple sclerosis, diabetes and cancer but also of major depression. If chronic inflammatory changes are a common feature of depression, this could predispose depressed patients to neurodegenerative changes in later life. Indeed there is now clinical evidence that depression is a common antecedent of Alzheimer's disease and may be an early manifestation of dementia before the cognitive declines becomes apparent. This review summarises the evidence that links chronic low grade inflammation with changes in brain structure that could precipitate neurodegenerative changes associated with Alzheimer's disease and other dementias. For example, neuronal loss is a common feature of major depression and dementia. It is hypothesised that the progress from depression to dementia could result from the activation of macrophages in the blood, and microglia in the brain, that release pro-inflammatory cytokines. Such cytokines stimulate a cascade of inflammatory changes (such as an increase in prostaglandin E2, nitric oxide in addition to more pro-inflammatory cytokines) and a hypersecretion of cortisol. The latter steroid inhibits protein synthesis thereby reducing the synthesis of neurotrophic factors and preventing reairto damages neuronal networks. In addition, neurotoxic end products of the tryptophan-kynurenine pathway, such as quinolinic acid, accumulate in astrocytes and neurons in both depression and dementia. Thus increased neurodegeneration, reduced neuroprotection and neuronal repair are common pathological features of major depression and dementia. Such changes may help to explain why major depression is a frequent prelude to dementia in later life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The progression from depression to dementia could result from increased levels of pro-inflammatory cytokines, which stimulate a cascade of inflammatory changes and a hypersecretion of cortisol and which also induce the production of neurotoxic end products of the tryptophan–kynurenine pathway (Leonard, 2007).”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Leonard, 2007
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“[76] have provided an explanation by demonstrating that antidepressants increase the number of new hippocampal neurons in the rat brain, changes that are correlated with improved behavioural function [77].”
BackgroundChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“[76] have provided an explanation by demonstrating that antidepressants increase the number of new hippocampal neurons in the rat brain, changes that are correlated with improved behavioural function [77].”
BackgroundPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1×
“The neuritic plaques contain aggregated beta-amylaloid (Ab) that is assumed to impair neuronal function in addition to inducing the inflammatory response [39, 40].”
BackgroundOxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · cited 1×
“In addition, the activity of IDO was found to increase in Alzheimer’s, a change that is correlated with an altered immune and oxidative stress response [71, 72].”
BackgroundActivation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071 · cited 1×
“Chronic inflammation is now considered to be central to the pathogenesis not only of depression but also of cardiovascular disease, diabetes and cancer, conditions that are frequently comorbid with major depression [7].”
BackgroundPain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,064
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 1×
“Support for the macrophage theory of depression, originally suggested by Smith [26], comes from studies in patients with various types of cancer, or hepatitis, who have been treated with IFN.”
BackgroundChildhood trauma associated with smaller hippocampal volume in women with major depression
Vythilingam, M., Heim, C., Newport, J., Miller, A. H., Anderson, E., Bronen, R., Brummer, M., Staib, L., Vermetten, E., Charney, D. S., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2072 · Cited by 812 · cited 1×
“Thus there is both clinical and experimental evidence that exposure to severe stress during critical periods of brain development (for example, early childhood trauma) have lasting effects on brain structure and function [75].”
BackgroundDepression and immunity: A meta-analytic review.
Herbert, T. B., & Cohen, S. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.113.3.472 · Cited by 803 · cited 1×
“There is evidence that activation, rather than suppression, of the innate immune system occurs [5].”
BackgroundEndogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768 · cited 1×
“The neurotoxic effects of QA and 3-OHK reside in their ability to stimulate NMDA receptors in contrast to kynurenine, that is reduced in depression and dementia, that acts as an antagonist of NMDA receptors and therefore confers some neuroprotective effects [67, 68].”
BackgroundSairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · cited 7×
“M-CSF = macrophage colony stimulating factor, MCP 1 = macrophage chemoattractant protein, (+) increased, (-) decreased, (?) insufficient published data, Ab = beta amyloid, NFT’s = neurofibrillary tangles.”
BackgroundInfluentialALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715 · cited 1×
“Although most attention has been directed towards the neurotoxic effects of Ab and NFT in Alzheimer’s disease, there is evidence that the kynurenine pathway also plays a pathological role, together with oxidative stress and lipid peroxidation of the neuronal membranes [70].”
BackgroundMajor Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Ford, D. E., & Erlinger, T. P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.1010 · Cited by 544
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Depression and Chronic Medical Illness
Sachdeva, S., Cohen, D., Singh, A. K., Kaul, P., & Schwartz, T. L. (2009) · Medical Psychiatry · doi:10.3109/9781420084887.012 · Cited by 496
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473
Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Depression in Alzheimer’s disease: overview and treatment
Lyketsos, C. G., & Olin, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01348-3 · Cited by 394 · cited 1×
“incidence of depression is reported to occur in approximately 50% of patients with this disorder [63].”
BackgroundIndicators of immune activation in major depression
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384 · cited 1×
“changes [24, 25].”
Depression and chronic medical illness.
Katon, W., & Sullivan, M. D. (1990) · PubMed · Cited by 383
Depression in multiple sclerosis
Minden, S. L., Orav, J., & Reich, P. (1987) · General Hospital Psychiatry · doi:10.1016/0163-8343(87)90052-1 · Cited by 382
The cell biology of neuronal navigation
Song, H.-J., & Poo, M.-M. (2001) · Nature Cell Biology · doi:10.1038/35060164 · Cited by 379 · cited 1×
“Antidepressants are known to enhance axonal and dendritic sprouting [80, 81], changes that are initiated by the synthesis of neurotrophic factors that are vital for the selection and stabilisation of synaptic contacts [82].”
BackgroundCytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 2×
“In addition to the changes in the pro-inflammatory cytokines, there is also evidence that effective antidepressant treatment largely attenuates the inflammatory changes [24, 25 ].”
BackgroundSelf-citationTRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE
FLANDERS, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00066-x · Cited by 364
Cerebrospinal Cytokine Levels in Patients with Acute Depression
Levine, J., Barak, Y., Chengappa, K. N. R., Rapoport, A., Rebey, M., & Barak, V. (1999) · Neuropsychobiology · doi:10.1159/000026615 · Cited by 354 · cited 7×
“M-CSF = macrophage colony stimulating factor, MCP 1 = macrophage chemoattractant protein, (+) increased, (-) decreased, (?) insufficient published data, Ab = beta amyloid, NFT’s = neurofibrillary tangles.”
BackgroundInfluentialGeerlings, M. I., Bouter, L. M., Schoevers, R. A., Beekman, A. T. F., Jonker, C., Deeg, D. J. H., Van Tilburg, W., Adèr, H. J., & Schmand, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.6.568 · Cited by 352 · cited 1×
“If chronic inflammatory changes are a common feature of major depression, what could be the long-term outcome? Depression has ‘been indicated as a common antecedent of Alzheimer’s disease and may be an early manifestation of dementia before the cognitive decline becomes apparent [8].”
BackgroundTarkowski, E., Blennow, K., Wallin, A., & Tarkowski, A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020568013953 · Cited by 349
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329 · cited 1×
“It must be noted that not all studies have found an association between inflammation and the pathogenesis of depression [19, 20] while in some studies the association between inflammation and the symptoms of depression is substantially reduced when factors such as the body mass index, gender and personality are factor…”
BackgroundIncreased interleukin-6 expression by microglia from brain of aged mice
Ye, S.-M., & Johnson, R. W. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00217-3 · Cited by 327
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308
Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS
Hewett, S. I., Csernansky, C. A., & Choi, D. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90362-x · Cited by 297 · cited 1×
“It is known that IL-1induces the expression of inducible nitric oxide synthase (iNOS) by astrocytes which could indirectly potentiate NMDA induced neurotoxicity [41].”
BackgroundBLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures
Vaidya, V. A., Siuciak, J. A., Du, F., & Duman, R. S. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00289-9 · Cited by 276
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264 · cited 2×
“Thus IL-6 drives the acute phase response that contributes to neuronal injury [45].”
BackgroundHuman microglia convert l-tryptophan into the neurotoxin quinolinic acid
HEYES, M. P., ACHIM, C. L., WILEY, C. A., MAJOR, E. O., SAITO, K., & MARKEY, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults
Miller, G. E., Freedland, K. E., Carney, R. M., Stetler, C. A., & Banks, W. A. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(03)00057-6 · Cited by 248 · cited 1×
“It must be noted that not all studies have found an association between inflammation and the pathogenesis of depression [19, 20] while in some studies the association between inflammation and the symptoms of depression is substantially reduced when factors such as the body mass index, gender and personality are factor…”
BackgroundRepeated stress increases catalytic TrkB mRNA in rat hippocampus
Nibuya, M., Takahashi, M., Russell, D. S., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00335-3 · Cited by 236
Negative Affect as a Prospective Risk Factor for Hypertension
Jonas, B. S., & Lando, J. F. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200003000-00006 · Cited by 234 · cited 1×
“Thus chronic inflammatory changes are known to occur in major depression and are often associated with cardiac disease, hypertension, diabetes and different types of autoimmune disease [3, 4].”
BackgroundAnterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222 · cited 1×
“The changes in the cingulate cortex may represent an increased sensitivity of the patient to conflict and negative life events [ 37 ].”
BackgroundNeuropsychological Differences Between Late-Onset and Recurrent Geriatric Major Depression
Rapp, M. A., Dahlman, K., Sano, M., Grossman, H. T., Haroutunian, V., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.691 · Cited by 219 · cited 1×
“depression earlier in life [64].”
Strijbos, P., & Rothwell, N. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03468.1995 · Cited by 214
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00047 · Cited by 208 · cited 1×
“The neuritic plaques contain aggregated beta-amylaloid (Ab) that is assumed to impair neuronal function in addition to inducing the inflammatory response [ 39 , 40].”
BackgroundInflammatory Proteins and Depression in the Elderly
Tiemeier, H., Hofman, A., van Tuijl, H. R., Kiliaan, A. J., Meijer, J., & Breteler, M. M. B. (2003) · Epidemiology · doi:10.1097/00001648-200301000-00025 · Cited by 206 · cited 1×
“It is also apparent that when statistically significant changes do occur, there is considerable variability in the inflammatory parameters that are determined, the significance of the difference between the patients and the control population being attributed to a subgroup of patients only [23].”
BackgroundSong, C., Dinan, T., & Leonard, B. E. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90135-x · Cited by 193
Self-citationMcCusker, S. M., Curran, M. D., Dynan, K. B., McCullagh, C. D., Urquhart, D. D., Middleton, D., Patterson, C. C., McIlroy, S. P., & Peter Passmore, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04008-3 · Cited by 191
Fujioka, T., Fujioka, A., & Duman, R. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1065.03.2004 · Cited by 191 · cited 1×
“Antidepressants are known to enhance axonal and dendritic sprouting [80, 81], changes that are initiated by the synthesis of neurotrophic factors that are vital for the selection and stabilisation of synaptic contacts [82].”
BackgroundHerx, L. M., Rivest, S., & Yong, V. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2232 · Cited by 190
Suarez, E. C., Lewis, J. G., Krishnan, R. R., & Young, K. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.01.002 · Cited by 185 · cited 1×
“While there is now a substantial body of evidence associating an increase in pro-inflammatory cytokines in major depression, there is also evidence that qualitatively similar changes also occur in milder forms of the disorder and also in patients suffering from fatigue and severe insomnia [16, 17].”
BackgroundInterleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine
Gavin Norris, J., & Benveniste, E. N. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90174-w · Cited by 180
Lanzrein, A.-S., Johnston, C. M., Perry, V. H., Jobst, K. A., King, E. M., & Smith, A. D. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00016 · Cited by 178
Yu, Y. W. ‐., Chen, T., Hong, C., Chen, H.-M., & Tsai, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300172 · Cited by 172 · cited 1×
“These abnormal variants are associated with an increased risk of depression and a reduced ‘responsiveness to antidepressant treatments [14, 15].”
BackgroundHeyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., & Vickers, J. H. (1993) · Brain · doi:10.1093/brain/116.6.1425 · Cited by 170 · cited 2×
“A decrease in the concentration of kynurenic acid has been detected in the CSF of patients with Alzheimer’s [71].”
BackgroundSteffens, D. C., Plassman, B. L., Helms, M. J., Welsh-Bohmer, K. A., Saunders, A. M., & Breitner, J. C. S. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00247-8 · Cited by 169 · cited 1×
“This suggests that depression may be a prodrome of dementia [9].”
BackgroundRaised levels of plasma interleukin‐1β in major and postviral depression
Owen, B. M., Eccleston, D., Ferrier, I. N., & Young, H. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00162.x · Cited by 165
TGF‐β1 is an organizer of responses to neurodgeneration
Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R., & Pasinetti, G. M. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530408 · Cited by 165
Fauerbach, J. A., Heinberg, L. J., Lawrence, J. W., Munster, A. M., Palombo, D. A., Richter, D., Spence, R. J., Stevens, S. S., Ware, L., & Muehlberger, T. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200007000-00017 · Cited by 165
Qiu, Z., Sweeney, D. D., Netzeband, J. G., & Gruol, D. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10445.1998 · Cited by 159
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Hartai, Z., Juhász, A., Rimanóczy, Á., Janáky, T., Donkó, T., László, A., Penke, B., Tóth, G. K., Janka, Z., & Kalman, J. L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.012 · Cited by 150 · cited 1×
“Recently it has also been shown that the concentration of kynurenic acid in the red blood cells of patients with Alzheimer’s was significantly decreased while those of kynurenine, the precursor of 3OHK and QA, was unchanged [73].”
BackgroundPrefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Quinolinate neurotoxicity in cortical cell culture
Kim, J. P., & Choi, D. W. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90066-2 · Cited by 144 · cited 1×
“The neurotoxic effects of QA and 3-OHK reside in their ability to stimulate NMDA receptors in contrast to kynurenine, that is reduced in depression and dementia, that acts as an antagonist of NMDA receptors and therefore confers some neuroprotective effects [67, 68].”
BackgroundSTEPTOE, A., KUNZ-EBRECHT, S. R., & OWEN, N. (2003) · Psychological Medicine · doi:10.1017/s0033291702007250 · Cited by 139 · cited 1×
“It must be noted that not all studies have found an association between inflammation and the pathogenesis of depression [19, 20] while in some studies the association between inflammation and the symptoms of depression is substantially reduced when factors such as the body mass index, gender and personality are factor…”
BackgroundKanne, S. M., Balota, D. A., Storandt, M., McKeel, D. W., & Morris, J. C. (1998) · Neurology · doi:10.1212/wnl.50.4.979 · Cited by 116 · cited 1×
“Alzheimer’s disease, there is a profound atrophy of the hippocampus, frontal and parietal cortices [62] and that the”
BackgroundJun, T.-Y., Pae, C.-U., Hoon-Han, &., Chae, J.-H., Bahk, W.-M., Kim, K.-S., & Serretti, A. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00008 · Cited by 113
Gadient, R. A., & Otten, U. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90065-s · Cited by 86
Interleukin-1B polymorphism is associated with age at onset of Alzheimer’s disease
Sciacca, F. L., Ferri, C., Licastro, F., Veglia, F., Biunno, I., Gavazzi, A., Calabrese, E., Boneschi, F. M., Sorbi, S., Mariani, C. B., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00011-3 · Cited by 82
Allergy and depression: A neurochemical threshold model of the relation between the illnesses.
Marshall, P. S. (1993) · Psychological Bulletin · doi:10.1037//0033-2909.113.1.23 · Cited by 81 · cited 1×
“Depression is also frequently associated with inflammatory diseases such as multiple sclerosis [29], allergies of different types [30], and rheumatoid arthritis [31], diseases in which pro-inflammatory cytokines are over-expressed [32].”
BackgroundInflammation and depression: Is there a causal connection with dementia?
E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76 · cited 1×
“This has been the subject of a recent review [74].”
BackgroundSelf-citationNeurological and Psychiatric Adverse Effects of Immunological Therapy
Meyers, C. A., & Valentine, A. D. (1995) · CNS Drugs · doi:10.2165/00023210-199503010-00006 · Cited by 75 · cited 1×
“The changes induced by IFN in otherwise psychiatrically normal patients are probably a consequence of changes in the endocrine, neurotransmitter and immune systems rather than being a reflection of the pathological condition for which IFN was being administered [28].”
BackgroundSong, C., Horrobin, D., & Leonard, B. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-941557 · Cited by 69
Self-citationMitrasinovic, O. M., Perez, G. V., Zhao, F., Lee, Y. L., Poon, C., & Murphy, G. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104265200 · Cited by 61 · cited 1×
“M-CSF, in vitro, causes the augmentation of Ab induced cytokine, chemokine and NO synthesis [59].”
BackgroundHerpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion
van der Ven, A., van Diest, R., Hamulyák, K., Maes, M., Bruggeman, C., & Appels, A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000058378.50240.80 · Cited by 46 · cited 1×
“While there is now a substantial body of evidence associating an increase in pro-inflammatory cytokines in major depression, there is also evidence that qualitatively similar changes also occur in milder forms of the disorder and also in patients suffering from fatigue and severe insomnia [16, 17].”
BackgroundSchrott, L. M., & Crnic, L. S. (1996) · Brain Behavior and Immunity · doi:10.1006/brbi.1996.0023 · Cited by 38 · cited 1×
“Depression is also frequently associated with inflammatory diseases such as multiple sclerosis [29], allergies of different types [30], and rheumatoid arthritis [31], diseases in which pro-inflammatory cytokines are over-expressed [32].”
BackgroundInfante, J., Llorca, J., Berciano, J., & Combarros, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00453-6 · Cited by 24
Biochemical and pharmacological aspects of depression
(1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90636-z · Cited by 20
Knezevic-Cuca, J., Stansberry, K., Johnston, G., Zhang, J., Keller, E., Vinik, A., & Pittenger, G. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00151-4 · Cited by 20
Cytokines, Stress, and Depression
Leonard, B. E., & Song, C. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00111-2 · Cited by 9
Self-citationCann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Research works printed but not linked: 4
- Leonard BE (2006) Physical consequences of depression. Quart J mental Health 1:33–38
- Myint A-M, Leonard BE, Steinbusch HW, Kim Y-K (2005) Thi, Th2 and Th3 cytokine alteratikons in major depression. J Affect Dis 88:169–173
- Grimaldi LM, Casadrei VM, Ferri C et al (2000) Association of early onset Alzheimer’s disease with IL-1 alpha gene polymorphism. Ann Neurol 47:361–365 · doi:10.1002/1531-8249(200003)47:3<361::aid-ana12>3.0.co;2-n
- Hayaishi O Biochemical and medical aspects of tryptophan metabolism Elsevier: Amsterdam/North Holland Biomed (Press)
Cited by
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
Long-term psychiatric morbidities among SARS survivors
Mak, I. W. C., Chu, C. M., Pan, P. C., Yiu, M. G. C., & Chan, V. L. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.03.001 · Cited by 1,018
“Finally, there is emerging evidence concerning the role of neuroendocrine, neurostructural and neuroimmunological disturbances in psychiatric disorders such as depression and PTSD [32,42,43].”
BackgroundIntegrating neuroimmune systems in the neurobiology of depression
Wohleb, E. S., Franklin, T., Iwata, M., & Duman, R. S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.69 · Cited by 668
MacQueen, G., & Frodl, T. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.80 · Cited by 665
Metadata
- Authors
- Leonard, B. E.
- Affiliations
- National University of Ireland (IE)
- Corresponding author
- Leonard, Brian E.
- Venue
- Neurochemical Research
- Published
- 2007-08-20
- Volume
- 32
- Issue
- 10
- Pages
- 1749-1756
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2077733133
- Cited by
- 342
- References
- 83
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 15 · 2022: 20 · 2021: 19 · 2020: 17 · 2019: 20 · 2018: 14 · 2017: 17 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 18 · 2012: 26
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- chronic inflammation, depression, dementia, Alzheimer's disease, neurodegeneration, microglia, macrophages, inflammatory cytokines, cortisol, kynurenine pathway, quinolinic acid, neurotrophic factors, neuronal loss, astrocytes, neuroprotection
- MeSH terms
- Alzheimer Disease, Dementia, Depressive Disorder, Humans, Inflammation, Neurotoxins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.